ESSA Pharma to Present at the Jefferies London Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, Canada, Nov. 8, 2023 SOUTH SAN FRANCISCO , Calif. and VANCOUVER, Canada , Nov. 8, 2023 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Healthcare Conference on...